News | Patient Engagement | September 24, 2015

FDA Establishes Patient Engagement Committee

Committee will be developed by Center for Devices and Radiological Health to provide patient perspectives in regulatory decision-making

FDA, CDRH, Patient Engagement Advisory Committee, regulatory decision-making

September 24, 2015 — The U.S. Food and Drug Administration (FDA) announced it is establishing an advisory committee focused on patient engagement. The Patient Engagement Advisory Committee will provide advice on complex issues relating to medical devices, the regulation of devices and their use by patients to the FDA Commissioner.

The FDA’s Center for Devices and Radiological Health (CDRH) will lead development of the committee, focusing on including the views of patients during the medical device development process and considering patient perspectives in regulatory decision-making. CDRH engages patients throughout the regulatory process who are interested in contributing their views, data and resources to increase early access to high-quality safe and effective medical devices, reduce adverse events, and improve communication about the risks and benefits that matter most to them.

Part of the FDA’s public health mission is to help patients be more aware of the healthcare options available to them. Alongside industry, patient groups, and other government agencies, the agency is actively engaging individual patients to help them understand how a disease or condition impacts their daily lives and their caregiver’s lives, and the types of treatment benefits and risks that matter the most to them.

Together with other centers and offices across the FDA, CDRH is testing and developing other ways to engage patients and capture their views through public workshops. The center hosted a Patient Preference Initiative Workshop and participated in the Center for Drug Evaluation and Research’s (CDER) patient-focused drug development meetings, which can help inform the FDA staff as they conduct benefit-risk assessments for products under review and advise drug sponsors on their drug development programs.

In addition, CDRH is a member of the Medical Device Innovation Consortium (MDIC), a nonprofit public-private partnership including National Institutes of Health, Centers for Medicare & Medicaid Services, Patient Centered Outcomes Research Institute (PCORI), medical device companies and trade associations, patient groups and other nonprofit organizations. In 2015, MDIC developed a framework for incorporating patient preferences into the device development and assessment process that can be used to develop, design and market devices that meet the needs of patients.

The Patient Engagement Advisory Committee will bring patients, patient advocacy groups and experts together for a broader discussion of important patient-related issues. Such discussions may help inform device innovation, development, evaluation and access and help the FDA meet its public health commitment to improve patients’ health and quality of life.

For more information:

Related Content

Global Afib Patient Registry Shows New Tools Needed to Assess Patient Risk
News | Patient Engagement | June 17, 2019
Initial results from the AVIATOR 2 international registry were presented as late-breaking clinical science at the...
Survey Finds Personalized Patient Engagement Improving But Still Lacking
News | Patient Engagement | February 12, 2019
Software company Pegasystems Inc. announced new survey data revealing the positive impact of quality patient engagement...
American Heart Association Launches Health Motivation Platform for Personalized Cardiovascular Care
News | Patient Engagement | April 26, 2018
April 26, 2018 — Patients battling cardiovascular diseases, and even people hoping to prevent heart disease and strok
Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement | October 19, 2017
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professio
AstraZeneca HealthCare Foundation Awards 2017 Connections for Cardiovascular Health Grants
News | Patient Engagement | September 28, 2017
September 28, 2017 — The AstraZeneca HealthCare Foundation’s Connections for Cardiovascular Health (CCH) program is a
CAMC, Charleston Area Medical Center, congestive heart failure readmissions, SmarTigr patient engagement system, TeleHealth Services
News | Patient Engagement | February 09, 2017
Charleston Area Medical Center (CAMC) has documented reduced readmissions for congestive heart failure (CHF), chronic...
Million Hearts Cardiovascular Disease Risk Reduction Model, CMS, reduce heart attacks and strokes, participants
News | Patient Engagement | July 22, 2016
July 22, 2016 — The Centers for Medicare & Medicaid Services (CMS) recently announced 516 awardees in 47 states,
Stepathlon, exercise, cardiovascular health, Anand Ganesan, ACC.16
News | Patient Engagement | April 20, 2016
April 20, 2016 — A competition that used technology to encourage and track physical activity was effective at...
Videos | Patient Engagement | March 21, 2016
Examples of patient engagement technologies for medical imaging to meet health IT Stage 3 Meaningful Use requirements
Paxeramed, CarePassport version 2.0, patient engagement app, HIMSS 2016
Technology | Patient Engagement | March 10, 2016
March 10, 2016 — Paxeramed Corp.